These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 36018274)

  • 1. Potential mechanisms for lung fibrosis associated with COVID-19 infection.
    Parimon T; Espindola M; Marchevsky A; Rampolla R; Chen P; Hogaboam CM
    QJM; 2023 Jul; 116(7):487-492. PubMed ID: 36018274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phosphodiesterase-4 inhibitor reduces lung inflammation and fibrosis in a hamster model of SARS-CoV-2 infection.
    Kolloli A; Ramasamy S; Kumar R; Nisa A; Kaplan G; Subbian S
    Front Immunol; 2023; 14():1270414. PubMed ID: 37854602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary fibrosis in COVID-19: mechanisms, consequences and targets.
    O'Reilly S
    QJM; 2023 Oct; 116(9):750-754. PubMed ID: 37191984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice.
    Dubuc I; Prunier J; Lacasse É; Gravel A; Puhm F; Allaeys I; Archambault AS; Gudimard L; Villano R; Droit A; Flamand N; Boilard É; Flamand L
    Front Immunol; 2022; 13():893792. PubMed ID: 35812400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dihydromyricetin on SARS-CoV-2 viral replication and pulmonary inflammation and fibrosis.
    Xiao T; Wei Y; Cui M; Li X; Ruan H; Zhang L; Bao J; Ren S; Gao D; Wang M; Sun R; Li M; Lin J; Li D; Yang C; Zhou H
    Phytomedicine; 2021 Oct; 91():153704. PubMed ID: 34419736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.
    Li S; Zhang Y; Guan Z; Li H; Ye M; Chen X; Shen J; Zhou Y; Shi ZL; Zhou P; Peng K
    Signal Transduct Target Ther; 2020 Oct; 5(1):235. PubMed ID: 33037188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and Molecular Mechanism of Pulmonary Fibrosis Post-COVID-19: Focus on Galectin-1, -3, -8, -9.
    Oatis D; Simon-Repolski E; Balta C; Mihu A; Pieretti G; Alfano R; Peluso L; Trotta MC; D'Amico M; Hermenean A
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overactive Epidermal Growth Factor Receptor Signaling Leads to Increased Fibrosis after Severe Acute Respiratory Syndrome Coronavirus Infection.
    Venkataraman T; Coleman CM; Frieman MB
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28404843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the combination of modern medicine and traditional Chinese medicine in pulmonary fibrosis arising as a sequelae in convalescent COVID-19 patients: a randomized multicenter trial.
    Lu ZH; Yang CL; Yang GG; Pan WX; Tian LG; Zheng JX; Lv S; Zhang SY; Zheng PY; Zhang SX
    Infect Dis Poverty; 2021 Mar; 10(1):31. PubMed ID: 33731163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Pathogenesis of Fibrosis, Thrombosis and Surfactant Dysfunction in the Lungs of Severe COVID-19 Patients.
    Krygier A; Szmajda-Krygier D; Świechowski R; Pietrzak J; Wosiak A; Wodziński D; Balcerczak E
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing incidence of lung transplantation in patients with post-COVID-19 pulmonary fibrosis.
    Khajotia R
    Pan Afr Med J; 2021; 40():169. PubMed ID: 34970411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients.
    Giacomelli C; Piccarducci R; Marchetti L; Romei C; Martini C
    Biochem Pharmacol; 2021 Nov; 193():114812. PubMed ID: 34687672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary fibrosis in patients with COVID-19: A review].
    Chuchalin AG
    Ter Arkh; 2022 Dec; 94(11):1333-1339. PubMed ID: 37167174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary fibrosis: A short- or long-term sequelae of severe COVID-19?
    Zheng Z; Peng F; Zhou Y
    Chin Med J Pulm Crit Care Med; 2023 Jun; 1(2):77-83. PubMed ID: 37388822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing of histone deacetylase inhibitors: A promising strategy to combat pulmonary fibrosis promoted by TGF-β signalling in COVID-19 survivors.
    P KM; Sivashanmugam K; Kandasamy M; Subbiah R; Ravikumar V
    Life Sci; 2021 Feb; 266():118883. PubMed ID: 33316266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice.
    Dinnon KH; Leist SR; Okuda K; Dang H; Fritch EJ; Gully KL; De la Cruz G; Evangelista MD; Asakura T; Gilmore RC; Hawkins P; Nakano S; West A; Schäfer A; Gralinski LE; Everman JL; Sajuthi SP; Zweigart MR; Dong S; McBride J; Cooley MR; Hines JB; Love MK; Groshong SD; VanSchoiack A; Phelan SJ; Liang Y; Hether T; Leon M; Zumwalt RE; Barton LM; Duval EJ; Mukhopadhyay S; Stroberg E; Borczuk A; Thorne LB; Sakthivel MK; Lee YZ; Hagood JS; Mock JR; Seibold MA; O'Neal WK; Montgomery SA; Boucher RC; Baric RS
    Sci Transl Med; 2022 Sep; 14(664):eabo5070. PubMed ID: 35857635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenesis of pulmonary fibrosis].
    Rybakova MG; Myurzep AE
    Arkh Patol; 2024; 86(4):58-63. PubMed ID: 39073544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Pathology of End-Stage COVID-19 Disease in Explanted Lungs and Outcomes After Lung Transplantation.
    Flaifel A; Kwok B; Ko J; Chang S; Smith D; Zhou F; Chiriboga LA; Zeck B; Theise N; Rudym D; Lesko M; Angel L; Moreira A; Narula N
    Am J Clin Pathol; 2022 Jun; 157(6):908-926. PubMed ID: 34999755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Middle East Respiratory Syndrome-Coronavirus Infection into Established hDPP4-Transgenic Mice Accelerates Lung Damage Via Activation of the Pro-Inflammatory Response and Pulmonary Fibrosis.
    Kim J; Yang YL; Jeong Y; Jang YS
    J Microbiol Biotechnol; 2020 Mar; 30(3):427-438. PubMed ID: 31838832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.